Arkin Bio Capital
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Early Stage, Growth, Late Stage, Pre-IPO
Geographical Focus
United States, United Kingdom, Canada, Germany, Hong Kong, Japan, Australia, Singapore, China, India, Brazil, France, Switzerland, Mexico, South Korea, South Africa, Russia, Israel, Taiwan
Industries Focus
- Healthcare
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Medical Research
- Clinical Trials
- Regenerative Medicine
- Oncology
- Immunology
- Genomics
- Biopharmaceuticals
- Cell Therapy
- Gene Therapy
Investment Size:
5,000,000 to 50,000,000 USD
Investor Details Founded: 2010
Arkin Bio Capital is a prominent venture capital firm specializing in the life sciences sector, focusing on early to late-stage biotechnology companies. With a strong emphasis on immunology and oncology, the firm seeks to invest in innovative companies developing groundbreaking therapies in areas of high unmet medical need. Their portfolio includes companies involved in gene therapy, RNA/DNA-based therapies, and targeted treatments for various diseases.
The firm's investment strategy is characterized by a hands-on approach, providing not only capital but also strategic guidance to portfolio companies. Arkin Bio Capital leverages its extensive network and scientific expertise to support the growth and success of its investments. The firm has a proven track record of successful exits, including the acquisition of HI-Bio by Biogen for $1.15 billion upfront and up to $650 million in potential milestone payments, totaling up to $1.8 billion.
Arkin Bio Capital operates as part of Arkin Holdings, a multi-asset investment manager with over $2 billion under management across various funds. The firm's leadership includes Managing Partners Pini Orbach and Alon Lazarus, who bring extensive experience in biopharmaceuticals, drug development, and business management. Their combined expertise enables Arkin Bio Capital to identify and nurture promising life science companies worldwide, driving impactful advancements in the biotechnology industry.
Requirements
- Innovative therapies in areas of high unmet medical need
- Strong scientific and clinical evidence supporting the product
- Experienced management team with a clear strategic vision
- Potential for significant market impact and growth
- Alignment with Arkin Bio Capital's investment focus on immunology and oncology
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Contact Number Hidden]
Portfolio Companies
- HI-Bio
- Keros Therapeutics
- Eleos Health
- Laguna
- Cellebrite
- TopGum Industries
- Reches Real Estate
- Fu-Gen
- DigitalOcean
- LendBuzz
- The Legacy at Baton Rouge
- Argo Properties NV
Claim this Investor
Are you an official representative of Arkin Bio Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim